AptarGroup, Inc. 10-Q Summary: Quarter Ended September 30, 2007
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2007, and the nine-month period ended on that date. AptarGroup, Inc. operates in the packaging components industry, developing and selling consumer product dispensing systems across three segments: Beauty & Home, Closures, and Pharma. The company is a large accelerated filer incorporated in Delaware.
Key Financial Metrics
| Metric | Q3 2007 | Q3 2006 | 9M 2007 | 9M 2006 |
|---|---|---|---|---|
| Net Sales | $485.7 million | $404.9 million | $1,408.4 million | $1,179.0 million |
| Operating Income | $57.4 million | $44.6 million | $161.6 million | $120.8 million |
| Net Income | $39.4 million | $28.2 million | $105.9 million | $75.7 million |
| Diluted EPS | $0.56 | $0.40 | $1.48 | $1.05 |
| Operating Margin | 11.8% | 11.0% | 11.5% | 10.3% |
| Effective Tax Rate | 27.8% | 31.4% | 30.2% | 31.5% |
| Cash & Equivalents | $270.1 million | $170.6 million (Dec 31, 2006) | N/A | |
| Total Debt (Short & Long Term) | $353.6 million | $296.3 million (Dec 31, 2006) | N/A | |
| Net Cash Provided by Operations (9M) | N/A | $186.8 million | $148.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 20% in Q3 and 19% for the nine months ended September 30, 2007, compared to the prior year. Approximately 6% of this growth was attributed to favorable foreign exchange rates (weakening U.S. dollar), while 1% was due to acquisitions. The remainder was driven by increased demand for innovative dispensing systems.
- Profitability: Operating income rose 29% in Q3 and 34% for the nine-month period. Margins expanded due to favorable product mix (higher Pharma sales), improved manufacturing quality in the Pharma segment, and the leveraging of fixed costs against higher volumes.
- Cost Pressures: Cost of sales as a percentage of net sales increased slightly in Q3 (68.0% vs. 67.8%) due to rising raw material costs (nickel and plastic resin) and the impact of the weaker U.S. dollar on Euro-denominated costs. However, for the nine-month period, the ratio improved slightly to 67.4%.
- Segment Performance:
- Beauty & Home: Sales up 22% (Q3) and 22% (9M); Segment Income up 38% (Q3) and 42% (9M).
- Closures: Sales up 11% (Q3) and 12% (9M); Segment Income up 6% (Q3) and 15% (9M).
- Pharma: Sales up 28% (Q3) and 23% (9M); Segment Income up 35% (Q3) and 34% (9M), driven by strong demand for metered dose inhaler valves and nasal spray pumps.
- Acquisitions: The company acquired Moderne Verpackungssysteme GmbH (MVS) in February 2007 for approximately $5.2 million, adding to the Beauty & Home segment.
Guidance, Outlook, and Risks
- Outlook: Management expects sales to increase in the fourth quarter of 2007 compared to the prior year, excluding exchange rate changes. The continued weakness of the U.S. dollar is expected to have a positive impact on sales.
- Earnings Guidance: Diluted earnings per share for the fourth quarter of 2007 are anticipated to be in the range of $0.43 to $0.46, compared to $0.38 in the prior year.
- Capital Allocation: The company repurchased 545,000 shares in Q3 and approximately 1.6 million shares for $56.8 million in the first nine months. A quarterly dividend of $0.13 per share was declared on October 17, 2007.
- Risks and Contingencies:
- Foreign Exchange: Significant exposure to the Euro and other currencies; a strengthening U.S. dollar would have a dilutive effect.
- Raw Materials: Volatility in the cost of resin and nickel-based components.
- Redeployment Program: A workforce reduction plan in France is expected to cost $7–$9 million total, with completion expected in Q4 2007.
- Tax Uncertainties: Adoption of FIN 48 resulted in a $1.6 million increase in liability for income tax uncertainties, reducing retained earnings.
Investor Verification Checklist
- Verify the sustainability of the 20% sales growth rate, distinguishing between organic demand and foreign exchange translation effects.
- Monitor raw material costs (nickel and resin) and their impact on future gross margins, given the recent upward trend.
- Assess the progress and final cost of the French workforce redeployment program, which is expected to conclude in Q4 2007.
- Review the impact of the German tax law change (effective Jan 1, 2008) on future effective tax rates, which contributed to a lower rate in Q3 2007.
- Confirm the company's ability to maintain capital expenditure levels ($130–$140 million estimated for 2007) while funding share repurchases and dividends.